Literature DB >> 18379548

Incremental peritoneal dialysis: effects on the choice of dialysis modality, residual renal function and adequacy.

G Viglino1, L Neri, S Barbieri.   

Abstract

There is still disagreement on whether peritoneal dialysis (PD) should begin with a full dose (Full_Dial) or with incremental doses (Incr_Dial) to compensate for the amount of Kt/V no longer supplied by the residual renal function (RRF). The aim of this study is to assess the effects of an Incr_Dial protocol on the choice of dialysis modality, RRF, and adequacy. The Incr_Dial protocol in our center is as follows: for patients with a glomerular filtration rate (GFR)>5 ml min(-1), PD is initiated with two exchanges per day (continuous ambulatory PD (CAPD)) or four sessions per week (ambulatory PD (APD)); and hemodialysis (HD) is initiated with two sessions per week. The PD dose is then increased in proportion to the reduction in the GFR as follows: GFR< or =5 and >3 ml min(-1)=3 CAPD exchanges or five APD sessions; GFR <3 ml min(-1)=full dialysis dose (Full_Dial). The effects of the Incr_Dial protocol on the choice of dialysis modality were assessed on 87 patients (pts) (age: 69.3+/-13.1 years) who initiated dialysis between 1 January 2004 and 31 May 2007. The effects of Incr_Dial on RRF and dialytic adequacy were assessed in 11 pts treated with two CAPD exchanges per day for a total of 106 months (mean+/-s.d. 9.7+/-6.5), and then treated with three CAPD exchanges per day for an additional 105 months (9.4+/-8.3). The use of Incr_Dial determined the choice of PD in 27 of 44 pts (61.4%) without indications or contraindications to HD or PD. CAPD was chosen by 20 of these pts (74.1%), whereas APD was preferred by 6 of the 8 pts switched from Incr_Dial to Full_Dial. During Incr_Dial, a significant reduction in the loss of GFR of 2.4+/-3.1 ml min(-1) year(-1) was observed when compared to the pre-dialysis period. Incr_Dial allowed for adequate clearance, as confirmed by the Kt/V (2.07+/-0.2), protein nitrogen appearance (1.17+/-0.13), and biochemical parameters. Ultrafiltration (UF) with icodextrin (772+/-166 ml per exchange) provided a daily UF of 517+/-296 ml day(-1) and remained unchanged when the duration of the dwell time increased significantly from 12.3+/-1.4 to 17.5+/-2.6 h.

Entities:  

Mesh:

Year:  2008        PMID: 18379548     DOI: 10.1038/sj.ki.5002601

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  12 in total

1.  Incremental start to PD as experienced in Italy: results of censuses carried out from 2005 to 2014.

Authors:  Loris Neri; Giusto Viglino; Giancarlo Marinangeli; Anna Rachele Rocca; Alessandro Laudon; Antonino Ragusa; Gianfranca Cabiddu
Journal:  J Nephrol       Date:  2017-05-12       Impact factor: 3.902

2.  Old and new perspectives on peritoneal dialysis in Italy emerging from the Peritoneal Dialysis Study Group Census.

Authors:  Giancarlo Marinangeli; Gianfranca Cabiddu; Loris Neri; Giusto Viglino; Roberto Russo; Ugo Teatini
Journal:  Perit Dial Int       Date:  2012-03-01       Impact factor: 1.756

3.  Intermittent peritoneal dialysis: urea kinetic modeling and implications of residual kidney function.

Authors:  Steven Guest; Alp Akonur; Arshia Ghaffari; James Sloand; John K Leypoldt
Journal:  Perit Dial Int       Date:  2011-12-01       Impact factor: 1.756

4.  Incremental dialysis in ESRD: systematic review and meta-analysis.

Authors:  Carlo Garofalo; Silvio Borrelli; Toni De Stefano; Michele Provenzano; Michele Andreucci; Gianfranca Cabiddu; Vincenzo La Milia; Valerio Vizzardi; Massimo Sandrini; Giovanni Cancarini; Adamasco Cupisti; Vincenzo Bellizzi; Roberto Russo; Paolo Chiodini; Roberto Minutolo; Giuseppe Conte; Luca De Nicola
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

Review 5.  Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology.

Authors:  Vincenzo Bellizzi; Giuseppe Conte; Silvio Borrelli; Adamasco Cupisti; Luca De Nicola; Biagio R Di Iorio; Gianfranca Cabiddu; Marcora Mandreoli; Ernesto Paoletti; Giorgina B Piccoli; Giuseppe Quintaliani; Maura Ravera; Domenico Santoro; Serena Torraca; Roberto Minutolo
Journal:  J Nephrol       Date:  2016-08-27       Impact factor: 3.902

6.  Incremental peritoneal dialysis: a 10 year single-centre experience.

Authors:  Massimo Sandrini; Valerio Vizzardi; Francesca Valerio; Sara Ravera; Luigi Manili; Roberto Zubani; Bernardo J A Lucca; Giovanni Cancarini
Journal:  J Nephrol       Date:  2016-08-31       Impact factor: 3.902

7.  The Use of Incremental Peritoneal Dialysis in a Large Contemporary Peritoneal Dialysis Program.

Authors:  Ghada A Ankawi; Nancy I Woodcock; Arsh K Jain; Amit X Garg; Peter G Blake
Journal:  Can J Kidney Health Dis       Date:  2016-12-13

8.  "Ico-Alone" single nocturnal exchange to initiate peritoneal dialysis in patients with residual renal function-Five year, single centre experience.

Authors:  T Jeloka; P Sanwaria; L Chaudhari; A Periera
Journal:  Indian J Nephrol       Date:  2013-07

9.  Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.

Authors:  Hye Eun Yoon; Yoon Kyung Chang; Seok Joon Shin; Bum Soon Choi; Byung Soo Kim; Cheol Whee Park; Ho Cheol Song; Sun Ae Yoon; Dong Chan Jin; Yong-Soo Kim
Journal:  J Korean Med Sci       Date:  2014-09-02       Impact factor: 2.153

10.  Therapeutic Challenges to End-Stage Kidney Disease in a Patient with Tetralogy of Fallot.

Authors:  Ken Ohara; Tetsu Akimoto; Takuya Miki; Naoko Otani; Taro Sugase; Takahiro Masuda; Takuya Murakami; Toshimi Imai; Shin-Ichi Takeda; Yasuhiro Ando; Shigeaki Muto; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.